FIELD : medicine; pharmaceuticals.SUBSTANCE : group of inventions refers to pharmaceutical industry, namely to a composition for preventing or treating metabolic disorders of carbohydrates and/or fats in humans or animals. Composition for preventing or treating metabolic disorders of carbohydrates and/or fats in humans or animals, containing at least a mixture of molecules consisting of at least a water-alcohol extract of Chrysanthellum indicum, obtained from whole plant and/or elevated parts of Chrysanthellum indicum, and Cynara scolymus aqueous extract obtained from Cynara scolymus leaves, and water-alcohol extract Vaccinium myrtillus obtained from Vaccinium myrtillus foetus, water-alcohol extract Olea europaea, obtained from leaves Olea europaea, and synthetic piperine and/or extract Piper, containing piperine, in a certain amount. Composition for preventing or treating metabolic disorders of carbohydrates and/or fats in human or animal body, containing at least a mixture of dicopheyl-quinic acid, apigenin-7-O-glucuronide, monocofeil-quinic acid, piperine and oleuropein, where at least one of molecules, other than piperine, is a synthetic molecule. Method for preventing or treating pathological disorders of metabolism of carbohydrates and/or fats in humans or animals, involving administering the composition to a human or an animal as a drug or a food product.EFFECT : compositions described above act simultaneously on several regulatory processes, inhibit three enzymes, exhibit a synergetic effect in preventing or treating metabolic disorders of carbohydrates and/or fats in humans or animals.25 cl, 17 tbl, 12 dwg